scholarly article | Q13442814 |
P5530 | Altmetric DOI | 10.1136/BMJ.C2701 |
P6409 | CORE ID | 185458530 |
P6179 | Dimensions Publication ID | 1010032747 |
P356 | DOI | 10.1136/BMJ.C2701 |
P953 | full work available at URL | http://eprints.whiterose.ac.uk/81087 |
P3181 | OpenCitations bibliographic resource ID | 1926812 |
P932 | PMC publication ID | 2898925 |
P698 | PubMed publication ID | 20610512 |
P50 | author | Paul Stewart | Q42887432 |
Saaeha Rauz | Q51793723 | ||
Alexandra J. Sinclair | Q54255687 | ||
Jeremy W Tomlinson | Q61267776 | ||
Carl E Clarke | Q63919326 | ||
Michael A Burdon | Q114778985 | ||
Mark Lawden | Q114778986 | ||
P2093 | author name string | Peter Good | |
Elizabeth A Walker | |||
Alexandra K Ball | |||
Peter G Nightingale | |||
Timothy D Matthews | |||
Andrew Jacks | |||
P2860 | cites work | Interventions for idiopathic intracranial hypertension | Q24246672 |
Swelling of the optic nerve head: a staging scheme | Q24561732 | ||
Perioperative safety in the longitudinal assessment of bariatric surgery | Q24594848 | ||
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates | Q24652265 | ||
Randomized, controlled trials, observational studies, and the hierarchy of research designs | Q24670544 | ||
Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment | Q28222006 | ||
Ultrasonographic evaluation of optic disc swelling: comparison with CSLO in idiopathic intracranial hypertension | Q30914383 | ||
Topiramate: a review of preclinical, pharmacokinetic, and clinical data | Q32135911 | ||
Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography | Q33384584 | ||
Diagnostic criteria for idiopathic intracranial hypertension | Q34161245 | ||
Meta-analysis: pharmacologic treatment of obesity | Q34408897 | ||
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study | Q34699512 | ||
Exploring the pathogenesis of IIH: an inflammatory perspective | Q37233835 | ||
Effects of weight loss on the course of idiopathic intracranial hypertension in women | Q41753662 | ||
Headache Impact Test-6 (HIT-6) scores for migraine patients: Their relation to disability as measured from a headache diary | Q43122196 | ||
Withdrawal of sibutramine in Europe | Q43166872 | ||
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue | Q44924302 | ||
Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity | Q45082819 | ||
Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia | Q45300087 | ||
The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri) | Q47274308 | ||
Ventriculoperitoneal shunting for idiopathic intracranial hypertension. | Q51600700 | ||
Learning effect of standard automated perimetry in healthy individuals. | Q51949120 | ||
A six-item short-form survey for measuring headache impact: the HIT-6. | Q53363511 | ||
Pseudotumor cerebri treated by rice reduction diet. | Q54217550 | ||
CSF opening pressure: Reference interval and the effect of body mass index | Q57384713 | ||
Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss | Q70422189 | ||
[The new IHS classification. Background and structure] | Q80530851 | ||
P433 | issue | jul07 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | arterial hypertension | Q41861 |
idiopathy | Q594841 | ||
intracranial hypertension | Q18558125 | ||
P304 | page(s) | c2701 | |
P577 | publication date | 2010-07-07 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study | |
P478 | volume | 341 |
Q99585533 | 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial |
Q42584276 | A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension |
Q47660883 | A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. |
Q34608944 | A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. |
Q39805081 | A randomised controlled trial of treatment for idiopathic intracranial hypertension |
Q64066377 | A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics |
Q37710832 | Acute headache |
Q90474190 | Advances in the understanding of headache in idiopathic intracranial hypertension |
Q91938775 | Are CSF Pressure Factors Related to the Development of Post-dural Puncture Headache? |
Q42369171 | Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. |
Q91701623 | Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom |
Q37587255 | Bariatric Surgery or Non-surgical Weight Loss for Idiopathic Intracranial Hypertension? A Systematic Review and Comparison of Meta-analyses. |
Q34249708 | Cerebrospinal fluid and lumbar puncture: a practical review |
Q51084496 | Choroid plexus aquaporin 1 and intracranial pressure are increased in obese rats: towards an idiopathic intracranial hypertension model? |
Q57985150 | Diet and nutraceutical interventions for headache management: A review of the evidence |
Q91690662 | Endovascular Treatment for Venous Sinus Stenosis in Idiopathic Intracranial Hypertension: An Observational Study of Clinical Indications, Surgical Technique, and Long-Term Outcomes |
Q57294841 | European headache federation guideline on idiopathic intracranial hypertension |
Q51736876 | Evaluating the Fat Distribution in Idiopathic Intracranial Hypertension Using Dual-Energy X-ray Absorptiometry Scanning. |
Q64944879 | Evaluation and management of adult idiopathic intracranial hypertension. |
Q26765034 | Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management |
Q89538775 | Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting |
Q35041025 | Formula food-reducing diets:A new evidence-based addition to the weight management tool box. |
Q92381080 | Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension |
Q38236305 | Headache and the pseudotumor cerebri syndrome |
Q37860205 | Headache attributable to nonvascular intracranial disorders |
Q35620869 | Headache determines quality of life in idiopathic intracranial hypertension. |
Q38061011 | High-pressure headaches: idiopathic intracranial hypertension and its mimics |
Q41528844 | Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management. |
Q56060083 | Idiopathic intracranial hypertension |
Q36561779 | Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management |
Q90488399 | Idiopathic intracranial hypertension and bariatric surgery: a systematic review |
Q31155124 | Idiopathic intracranial hypertension in children: Diagnostic and management approach |
Q53196140 | Idiopathic intracranial hypertension is not benign: a long-term outcome study. |
Q26749288 | Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases |
Q89108010 | Idiopathic intracranial hypertension: consensus guidelines on management |
Q38148469 | Idiopathic intracranial hypertension; research progress and emerging themes. |
Q50110442 | Indications and technique for transconjunctival optic nerve sheath fenestration : Video article |
Q47289520 | Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). |
Q24187976 | Interventions for idiopathic intracranial hypertension |
Q47980503 | Intracranial hypertension induced by internal jugular vein stenosis can be resolved by stenting. |
Q37941981 | Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review |
Q41626158 | Long-term Response of Cerebrospinal Fluid Pressure in Patients with Idiopathic Intracranial Hypertension - A Prospective Observational Study |
Q53200381 | Lumbopleural Shunting as an Alternative Cerebrospinal Fluid Diversion Modality for Management of Idiopathic Intracranial Hypertension: Is It Time for a Change? |
Q89474410 | Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention |
Q56604602 | Neurophysiologic tests screening cognitive impairment in idiopathic intracranial hypertension patients |
Q92324773 | Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension |
Q37684467 | Obesity and headache: Part II--potential mechanism and treatment considerations. |
Q92275655 | Obesity, Ethnicity and Idiopathic Intracranial Hypertension |
Q48113865 | Ocular ultrasound for monitoring pseudotumor cerebri syndrome. |
Q47815168 | Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension |
Q36383569 | Over-drainage and persistent shunt-dependency in patients with idiopathic intracranial hypertension treated with shunts and bariatric surgery |
Q37987064 | Papilledema: are we any nearer to a consensus on pathogenesis and treatment? |
Q33585419 | Papilledema: epidemiology, etiology, and clinical management |
Q50021120 | Pediatric Intracranial Hypertension: a Current Literature Review |
Q88271180 | Perspectives on diagnosis and management of adult idiopathic intracranial hypertension |
Q88798671 | Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review |
Q34780008 | Pseudotumor cerebri: an update on treatment options |
Q41947767 | Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol |
Q61628181 | Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension |
Q46949609 | Reevaluation of presentation and course of idiopathic intracranial hypertension--a large cohort comprehensive study |
Q36997244 | Risperidone Induced Benign Intracranial Hypertension Leading to Visual Loss |
Q83978747 | Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension |
Q26745691 | The diagnosis and management of idiopathic intracranial hypertension and the associated headache |
Q57791445 | The expanding burden of idiopathic intracranial hypertension |
Q37855973 | The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. |
Q89092175 | Topiramate is more effective than acetazolamide at lowering intracranial pressure |
Q38678284 | Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. |
Q55059941 | Update on Idiopathic Intracranial Hypertension. |
Q35126814 | Update on idiopathic intracranial hypertension |
Q36529652 | Update on the pathophysiology and management of idiopathic intracranial hypertension |
Q37439414 | Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension |
Q53670852 | [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension]. |
Q89916883 | [Idiopathic intracranial hypertension] |
Q52877452 | [Pseudotumor cerebri syndrome]. |
Search more.